Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8486
DC FieldValueLanguage
dc.contributor.authorJ. Mecevska-Jovcevskaen_US
dc.contributor.authorS. Kuzmanovskaen_US
dc.contributor.authorS. Shubevska- Stratrovaen_US
dc.contributor.authorM. Grozdovska Naumovskaen_US
dc.contributor.authorS. Biljalien_US
dc.contributor.authorE. Petrovskaen_US
dc.date.accessioned2020-06-12T09:58:43Z-
dc.date.available2020-06-12T09:58:43Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8486-
dc.language.isoenen_US
dc.publisherDe Gruyteren_US
dc.relation.ispartofClinical Chemistry and Laboratory Medicineen_US
dc.titleTartrete resistant acid phosphatase (TRACP), osteocalcin (OC) and β-crosslaps (CTX) as markers for monitoring of an alendronate therapyen_US
dc.typeProceeding articleen_US
dc.relation.conferenceIFCC WorldLab Istanbul 2014-Istanbul 22-26 June, Turkeyen_US
dc.identifier.doi10.1515/cclm-2014-4012-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
конгрес Истанбул2014.doc240 kBMicrosoft WordView/Open
0145 Истанбул 2014.doc107.5 kBMicrosoft WordView/Open
Show simple item record

Page view(s)

72
checked on Apr 26, 2024

Download(s)

14
checked on Apr 26, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.